Reneo Pharmaceuticals Inc (RPHM)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-05-19 | 2025-05-15 | S Sale |
Cormorant Asset Management, LP Former 10% Owner |
1,813,439
-100.0%
1.85USD 3,363,023 |
1,813,439 -100.0% | 1.85 | USD 3,363,023 | |
| 2025-05-19 | 2025-05-15 | B Purchase | Large shareholder |
1,129,730
+inf%
1.85USD 2,090,001 |
1,129,730 +inf% | 1.85 | USD 2,090,001 | |
| 2025-05-19 | 2025-05-15 | B Purchase | Large shareholder |
270,270
+18.8%
1.85USD 500,000 |
270,270 +18.8% | 1.85 | USD 500,000 | |
| 2025-05-14 | 2025-05-12 | S Sale |
Cormorant Asset Management, LP Large shareholder |
24,300
-1.3%
1.99USD 48,236 |
24,300 -1.3% | 1.99 | USD 48,236 | |
| 2025-04-08 | 2025-04-07 | S Sale |
President and CEO Executive Director |
516
-12.3%
2.67USD 1,378 |
516 -12.3% | 2.67 | USD 1,378 | |
| 2025-04-08 | 2025-04-07 | S Sale |
Chief Financial Officer Officer |
1,844
-12.3%
2.67USD 4,925 |
1,844 -12.3% | 2.67 | USD 4,925 | |
| 2025-04-08 | 2025-04-04 | S Sale |
President and CEO Executive Director |
358
-7.9%
3.33USD 1,191 |
358 -7.9% | 3.33 | USD 1,191 | |
| 2025-04-08 | 2025-04-04 | S Sale |
Chief Financial Officer Officer |
1,278
-7.8%
3.33USD 4,253 |
1,278 -7.8% | 3.33 | USD 4,253 | |
| 2024-09-26 | 2024-09-25 | B Purchase | Large shareholder |
68,746
+2.0%
1.50USD 102,872 |
68,746 +2.0% | 1.50 | USD 102,872 | |
| 2024-09-26 | 2024-09-24 | B Purchase | Large shareholder |
29,600
+0.9%
1.41USD 41,866 |
29,600 +0.9% | 1.41 | USD 41,866 | |
| 2024-09-19 | 2024-09-18 | B Purchase | Large shareholder |
806
+0.0%
1.40USD 1,128 |
806 +0.0% | 1.40 | USD 1,128 | |
| 2024-09-19 | 2024-09-17 | B Purchase | Large shareholder |
55,300
+1.7%
1.36USD 75,108 |
55,300 +1.7% | 1.36 | USD 75,108 | |
| 2024-09-16 | 2024-09-16 | B Purchase | Large shareholder |
172,747
+5.5%
1.37USD 236,871 |
172,747 +5.5% | 1.37 | USD 236,871 | |
| 2024-09-16 | 2024-09-13 | B Purchase | Large shareholder |
150,000
+5.0%
1.31USD 196,950 |
150,000 +5.0% | 1.31 | USD 196,950 | |
| 2024-09-16 | 2024-09-12 | B Purchase | Large shareholder |
36,176
+1.2%
1.40USD 50,523 |
36,176 +1.2% | 1.40 | USD 50,523 | |
| 2024-08-14 | 2024-08-14 | B Purchase | Large shareholder |
100,487
+3.5%
1.41USD 142,008 |
100,487 +3.5% | 1.41 | USD 142,008 | |
| 2024-08-14 | 2024-08-13 | B Purchase | Large shareholder |
171,339
+6.4%
1.39USD 238,590 |
171,339 +6.4% | 1.39 | USD 238,590 | |
| 2024-05-16 | 2024-05-14 | B Purchase | Large shareholder |
335,000
+14.3%
1.54USD 515,900 |
335,000 +14.3% | 1.54 | USD 515,900 | |
| 2024-05-16 | 2024-05-14 | B Purchase | Large shareholder |
79,281
+3.5%
1.56USD 123,678 |
79,281 +3.5% | 1.56 | USD 123,678 | |
| 2023-08-29 | 2023-08-28 | S Sale |
Chief Development Officer Officer |
15,625
-28.3%
6.28USD 98,058 |
15,625 -28.3% | 6.28 | USD 98,058 |